Top Markets
Coin of the day
Aptose Biosciences Inc. Aptose Biosciences Inc.

Aptose Biosciences Inc.

APS
Κατάταξη σε μετοχές #35076
Aptose Biosciences Inc. is a clinical-stage biotechnology firm dedicated to... Aptose Biosciences Inc. is a clinical-stage biotechnology firm dedicated to discovering and advancing personalized therapeutic solutions for challenging oncology cases, primarily within the United States. Its robust pipeline features several key clinical programs: APTO-253, currently in Phase 1a/b trials, targets patients with relapsed or refractory blood cancers like acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS). Another candidate, HM43239, is undergoing Phase 1/2 evaluation for the treatment of relapsed or refractory AML. Aptose is also developing luxeptinib, which is in Phase 1a/b clinical studies for individuals battling relapsed or refractory B-cell malignancies, encompassing chronic lymphocytic leukemia, small lymphocytic lymphoma, various non-Hodgkin's lymphomas, as well as AML and HR MDS. Furthermore, the company is progressing with APL-581, a program centered on a dual bromodomain and extra-terminal domain motif protein and kinase inhibitor. Aptose maintains strategic alliances with CrystalGenomics, Inc. and OHM Oncology. Incorporated in 1986 and headquartered in Toronto, Canada, the company was formerly known as Lorus Therapeutics Inc., changing its name to Aptose Biosciences Inc. in August 2014.
Τιμή μετοχής
$1.76
Τελευταίος συγχρονισμός: 2026-07-03
Κεφαλαιοποίηση
$4.50M
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
41.53%
Χώρα
CA
Εμπόριο Aptose Biosciences Inc. (APS)

Κατηγορία

Ιστορικό τιμής μετοχής για την Aptose Biosciences Inc. (APS)
Υψηλότερη τιμή κλεισίματος: $1.76 στις 2026-07-01

Χαμηλότερη τιμή κλεισίματος: $4.49K στις 1996-04-01
Ιστορικό τιμής μετοχής της Aptose Biosciences Inc. από 1996 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) -4.34%
2025 677.87%
2024 -91.63%
2023 -72.76%
2022 -64.07%
2021 -64.29%
2020 12.71%
2019 99.28%
2018 11.56%
2017 62.99%
2016 -55.72%
2015 -58.73%
2014 -1.07%
2013 57.23%
2012 69.88%
2011 -81.30%
2010 -47.11%
2009 58.35%
2008 -77.14%
2007 -10.06%
2006 -14.70%
2005 -57.23%
2004 -28.50%
2003 124.84%
2002 -54.03%
2001 -22.17%
2000 55.42%
1999 161.59%
1998 -65.73%
1997 -16.29%
1996 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE